Clinical Trial: Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Sponsor and Collaborators
Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)

Contact
France
Centre Hospital Universitaire Hop Huriez
Lille, France, 59037
Contact: Mohamed Hebbar, MD
33-3-2044-5461
m-hebbar@chru-lille.fr

CHU de Grenoble - Hopital Michallon
Grenoble, France, 38043
Contact: Christine Rebischung 33-4-7676-5451

CHU Pitie-Salpetriere
Paris, France, 75651
Contact: Jean-Baptiste Meric, MD
33-1-4216-0471
jeanbaptiste.meric@psl.ap-hop-paris.fr

Hopital Tenon
Paris, France, 75970
Contact: Thierry Andre, MD
33-1-6177-0708
thierry.andre@tnn.ap-hop-paris.fr

Hopital Saint Antoine Recruiting
Paris, France, 75571
Contact: Olivier Rosmorduc, MD, PhD
33-1-4928-2382
olivier.rosmorduc@sat.aphp.fr

Clinique Saint Jean
Lyon, France, 69008
Contact: Gerard Lledo 33-4-7878-1051

Principal Investigator
Philippe Lechat
CHU Pitie-Salpetriere

ClinicalTrials.gov Identifier
NCT00274885
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs